agilon health, inc. (New York Stock Exchange:AGL)
| Market Cap | $1.52B+481.1% |
| Revenue (ttm) | $6.00B+2.0% |
| Net Income | -$106.04M+65.6% |
| EPS | -$6.69+64.3% |
| Shares Out | 16.80M |
| PE Ratio | n/a |
| Forward PE | 25.09 |
| Dividend | n/a |
| Ex-Dividend Date | Nov 16, 2011 |
| Volume | 266,323 |
| Open | $88.08 |
| Previous Close | $89.50 |
| Day's Range | $86.31 - $90.24 |
| 52-Week Range | $7.48 - $133.04 |
| Beta | 3.11 |
| Analysts | Hold |
| Price Target | $124.67(+38.15%) |
| Earnings Date | Feb 24, 2027 |
About AGL
Agilon Health, Inc. provides healthcare solutions specifically designed for older adults, delivered through local primary care physicians throughout the United States. As of December 31, 2021, the company served an approximate total of 238,000 senior clients. This figure included 186,300 individuals enrolled in Medicare Advantage plans and 51,700 recipients of Medicare fee-for-service benefits. The enterprise, which commenced operations in 2016, was initially incorporated as Agilon Health Topco, Inc. before rebranding to its current name, agilon health, inc., in March 2021. Its corporate headquarters are situated in Austin, Texas.
Analyst consensus
4 firms rating AGL in the last 3 months, one vote each. Issuer-paid research is not counted.
Next catalysts
- Feb 24, 2027Earnings report
$AGL stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in AGL holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by AGL's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
AGL Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New AGL patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to AGL from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in AGL
| IWMiShares Russell 2000 ETF | $29.38M |
| VTIVanguard Morningstar Total Stock Market ETF | $24.74M |
| GCLOGuggenheim Investment Grade CLO ETF | $22.29M |
| FNDASchwab Fundamental U.S. Small Company Index ETF | $14.04M |
| VXFVanguard Extended Market ETF | $11.99M |
| FESMFidelity Enhanced Small Cap ETF | $11.85M |
Estimated from each fund’s disclosed top holdings × AUM
Bull Case vs Bear Case
AI-generated from AGL’s recent data — informational, not investment advice
What’s Behind the Score
News check: Deutsche Bank maintained Buy rating despite trimming target; AGL features in momentum/strong buy lists and trading at bargain valuations with positive earnings commentary.
Recent Insider Activity
Frequently Asked Questions
ETFs that hold this stock
| GCLO | Guggenheim Investment Grade CLO ETF | 21.27% |
| SAWS | AAM Sawgrass U.S. Small Cap Quality Growth ETF | 2.54% |
| VAMO | Cambria Value and Momentum ETF | 2.18% |
| XHS | State Street SPDR S&P Health Care Services ETF | 1.92% |
| DMDV | AAM S&P Developed Markets High Dividend Value ETF | 1.28% |
| FYC | First Trust Small Cap Growth AlphaDEX Fund | 0.94% |
| LNGR | Global X Aging Population ETF | 0.48% |
| FSEG | Fidelity Enhanced Small Cap Growth ETF | 0.42% |
| FYX | First Trust Small Cap Core AlphaDEX Fund | 0.36% |
| ISMD | Inspire Small/Mid Cap ETF | 0.29% |
| PINK | Simplify Health Care ETF | 0.26% |
| PQIN | PGIM Quant Solutions Strategic Alpha International Equity ETF | 0.21% |
Weight is the stock’s share of each fund’s holdings.
